<!DOCTYPE html>
<meta charset="utf8"/>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<html>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header>
        <nav>
            <ul>
                <li><h1>QuiVoteQuoi?</h1></li>
            </ul>
            <ul>
                <li><a href="/subjects">Sujets</a></li>
            </ul>
        </nav>
    </header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>European Medicines Agency</h2>
            <h3>Sujets</h3>
            <ul>
                
                    
                    <li><a href="/subject/4.20.01">Médecine, maladies</a></li>
                
                    
                    <li><a href="/subject/4.20.04">Produits et industrie pharmaceutiques</a></li>
                
                    
                    <li><a href="/subject/4.20.05">Législation et police sanitaire</a></li>
                
                    
                    <li><a href="/subject/8.40.08">Agences et organes de l'Union</a></li>
                
            </ul>
            <h3>Votes</h3>
            
            <ul>
                
                <li><a href="/vote/134516">A9-0216/2021 - Nicolás González Casares - Am 97</a></li>
                
                <li><a href="/vote/134518">A9-0216/2021 - Nicolás González Casares - Am 155</a></li>
                
                <li><a href="/vote/134519">A9-0216/2021 - Nicolás González Casares - Am 153</a></li>
                
                <li><a href="/vote/134693">Agence européenne des médicaments - European Medicines Agency - Europäische Arzneimittel-Agentur - A9-0216/2021 - Nicolás González Casares - Am 4-73, 75-96, 98-125, 127-143, 145-152</a></li>
                
                <li><a href="/vote/134695">A9-0216/2021 - Nicolás González Casares - Am 74/1</a></li>
                
                <li><a href="/vote/134696">A9-0216/2021 - Nicolás González Casares - Am 74/2</a></li>
                
                <li><a href="/vote/134698">A9-0216/2021 - Nicolás González Casares - Am 126/1</a></li>
                
                <li><a href="/vote/134699">A9-0216/2021 - Nicolás González Casares - Am 126/2</a></li>
                
                <li><a href="/vote/134700">A9-0216/2021 - Nicolás González Casares - Am 144</a></li>
                
                <li><a href="/vote/134702">A9-0216/2021 - Nicolás González Casares - Am 1/1</a></li>
                
                <li><a href="/vote/134703">A9-0216/2021 - Nicolás González Casares - Am 1/2</a></li>
                
                <li><a href="/vote/134705">A9-0216/2021 - Nicolás González Casares - Am 2/1</a></li>
                
                <li><a href="/vote/134706">A9-0216/2021 - Nicolás González Casares - Am 2/2</a></li>
                
                <li><a href="/vote/134708">A9-0216/2021 - Nicolás González Casares - Am 3/1</a></li>
                
                <li><a href="/vote/134709">A9-0216/2021 - Nicolás González Casares - Am 3/2</a></li>
                
                <li><a href="/vote/135104">Agence européenne des médicaments - A9-0216/2021 - Nicolás González Casares - Proposition de la Commission 08/07/2021 12:06:26.161</a></li>
                
                <li><a href="/vote/135105">A9-0216/2021 - Nicolás González Casares - Renvoi (article 59, paragraphe 4, du règlement) 08/07/2021 12:06:26.161</a></li>
                
                <li><a href="/vote/138973">Agence européenne des médicaments - European Medicines Agency - Europäische Arzneimittel-Agentur - A9-0216/2021 - Nicolás González Casares - Accord provisoire - Am 156</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>